Professor Graham Collins

Professional statement

Professor Graham Collins is a highly expert and leading consultant haematologist. He has over 20 years of experience and specialises in the treatment of Hodgkin’s lymphoma, non-Hodgkin's lymphoma, and lymphoproliferative disorders, as well as the treatments immunotherapy, chemotherapy, and stem cell transplantation. Professor Collins sees patients privately at GenesisCare and Oxford University Hospitals NHS Foundation Trust, both in Oxford.  

Professor Collins obtained a MA in medicine science from the University of Cambridge in 1995 and went on to receive an MBBS in medicine from Queen Mary University of London in 1998. Following his initial training, he was awarded a DPhil in molecular pathology and undertook specialist training in haematology at the University of Oxford. Upon completion, he began his role as a consultant haematologist in Oxford, specialising in lymphoma. He is driven to improve his patient’s experience and outcome with lymphoma. 

Professor Collins remains active in research and has contributed to numerous peer-reviewed publications. Professor Collins takes part in clinical trials of novel treatments for various types of lymphoma. He was the lead investigator on multiple clinical trials investigating immunotherapies for Hodgkin lymphoma. 

In addition to his role as a consultant, Professor Collins is also the past chair of the UK Hodgkin Lymphoma Study group and T-cell lymphoma working group and a clinical expert on the National CAR T-cell therapy panel. He co-authored the national guidelines for relapsed and frontline Hodgkin’s lymphoma and T-cell lymphoma for the National Institute for Health and Care Excellence (NICE). He is joint programme director for the national specialist trainee lymphoma management course.